CVS Caremark Newswire (Page 4)

Comprehensive Real-Time News Feed for CVS Caremark. (Page 4)

Results 61 - 80 of 426 in CVS Caremark

  1. PayPal Here Adds Windows Support, Will Launch An EMV Card Reader Later This YearRead the original story w/Photo

    Jan 13, 2015 | TechCrunch

    ... many larger U.S. retailers have hastened to support EMV cards, including Walmart, as well as Sears, Target and CVS Caremark - all of whom have been rolling out support for EMV at an accelerated pace. But of some 12 million POS terminals that have to ...

    Comment?

  2. AKREA Makes a Big Buy in DallasRead the original story w/Photo

    Jan 13, 2015 | GlobeSt.com

    The acquisition by AKREA is the firm's second in the Dallas area; last year, it purchased Vista Point North in Lewisville. DALLAS-Miami, Fla.-based Adler Kawa Real Estate Advisors has made its biggest purchase yet.

    Comment?

  3. Former Family Dollar COO named president and COO of Fred'sRead the original story w/Photo

    Jan 13, 2015 | Chain Store Age

    ... supply chain management and store operations. Prior to Family Dollar, he spent more than 20 years with CVS Caremark, rising to the position of executive VP of merchandising, marketing, advertising, and supply chain. "The hiring of Mike Bloom as ...

    Comment?

  4. Fred's hires former Family Dollar exec as COORead the original story

    Jan 13, 2015 | Retailing Today

    ... store operations and supply chain management." Prior to Family Dollar, Bloom spent more than 20 years with CVS Caremark, holding a variety of positions with increasing responsibilities in merchandising and operations and rising finally to EVP ...

    Comment?

  5. AbbVie Stock Down After Guidance, DowngradeRead the original story w/Photo

    Jan 9, 2015 | Investor's Business Daily

    Shares of big pharma AbbVie dropped more than 3% Friday morning after the company issued 2015 EPS guidance and got downgraded by Bank of America. AbbVie said it expects full-year earnings of width=600 scrolling=no.25 to width=600 scrolling=no.45, the midpoint just above the average estimate of width=600 scrolling=no.32 among analysts polled by Thomson Reuters.

    Comment?

  6. AbbVie projects earnings growth in 2015Read the original story w/Photo

    Jan 9, 2015 | Business Journal

    Pharmaceutical company AbbVie is forecasting strong earnings growth this year, thanks in large part to continuing solid performance of Humira and the good prospects of a new hepatitis C treatment. Analysts' consensus expectation was for earnings of $4.33 per share, and AbbVie released guidance predicting a range of $4.25 to $4.45 per share , the Wall Street Journal reported.

    Comment?

  7. Study suggests link between e-cigarettes, respiratory infectionsRead the original story w/Photo

    Jan 9, 2015 | WTHR-TV Indianapolis

    ... small number, it can be a first sign of their mental decline, a new study finds. The national drug store chain CVS Caremark said Wednesday that it's phasing out the sale of tobacco products at its more than 7,600 stores across the United States. The ...

    Comment?

  8. Is Gilead Sciences Inc. Now a Takeover Target?Read the original story w/Photo

    Jan 9, 2015 | The Motley Fool

    ... forward price-to-earnings ratio at 9.88, compared to a sector average that tops 24. After striking a deal with CVS Caremark that secured preferred reimbursement status for its HCV drugs and essentially shut out competitor AbbVie 's Viekira Pak, ...

    Comment?

  9. New Orleans bar and casino workers deserve a smoke-free workplace: Jarvis DeBerryRead the original story w/Photo

    Jan 8, 2015 | The Times-Picayune

    ... in New York. CVS announced Wednesday, Sept. 3, 2014 that it will tweak its corporate name. Rhode Island-based CVS Caremark will now be known as CVS Health, and stores will stop the sale of tobacco nearly a month sooner than planned. The cigars and ...

    Comment?

  10. A physician investigates the American Board of Internal MedicineRead the original story w/Photo

    Jan 7, 2015 | Kevin, M.D.

    ... medical officer of Aetna in 2006, and now serves as the executive vice president and chief medical officer of CVS Caremark .) In 2002, this group published a white paper entitled "Medical Professionalism in the New Millennium: A Physician Charter" ...

    Comment?

  11. Assessing Gilead's Reality-Perception Gap: Upside Revenue SurpriseRead the original story w/Photo

    Jan 6, 2015 | Seeking Alpha

    AbbVie announced a deal with Express Scripts that has had a major impact on GILD's share price. CVS announced Monday it would make Gilead's hepatitis C pills the exclusive treatment option for beneficiaries on its Medicare, Medicaid and other drug benefit plans.

    Comment?

  12. Pharmacy giant CVS opts to exclusively offer Gilead's pricey hepatitis C drugRead the original story w/Photo

    Jan 5, 2015 | Business Journal

    Gilead Sciences Inc. , whose stock plummeted last month when Express Scripts Holding Co. chose to offer a competitor's hepatitis C drug, jumped Monday after CVS Health Corp. said Gilead's pill would be offered exclusively to patients on its drug benefit plans.

    Comment?

  13. Stocks Lose More Ground; Gilead Sciences RisesRead the original story w/Photo

    Jan 5, 2015 | Investor's Business Daily

    Stocks slid to fresh session lows late Monday as oil prices continued to weigh. West Texas Intermediate closed at $50.04 a barrel, down 5%.

    Comment?

  14. CVS offers prescription labels for visually impairedRead the original story

    Jan 5, 2015 | Chain Store Age

    CVS Health now offers the ScriptAbility prescription accessibility system through its mail service pharmacy to CVS/Caremark members who are blind or visually impaired. The system includes ScripTalk talking prescription labels, as well as braille and large print labels.

    Comment?

  15. Kentucky getting ready to switch insurance contractorsRead the original story w/Photo

    Dec 31, 2014 | Business Journal

    Anthem Inc. is the state's new medical benefit vendor starting in 2015. That contract previously was held by Louisville-based Humana Inc. Earlier this year, the state wrapped up a request for proposals process that sought vendors to administer benefits, Crystal Staley , executive director of the Kentucky Personnel Cabinet, told me in an email.

    Comment?

  16. A Dozen Stocks To Buy And Hold For 2015Read the original story w/Photo

    Dec 30, 2014 | Forbes.com

    ... that I am confident will be the super achievers in the new year. They are: Apple (AAPL), Bank of America (BAC), CVS Caremark (CVS), Facebook (FB), Google Class A (GOOGL), Home Depot (HD), Microsoft (MFST), Pfizer (PFE), TJX Cos. (TJX), UnitedHealth ...

    Comment?

  17. One Reason Rite Aid Could Soar HigherRead the original story w/Photo

    Dec 28, 2014 | Seeking Alpha

    Even after such a high share price appreciation, however, there could be additional upside given a major industry shift that's taking place. As the smallest player in the industry, this could present Rite Aid with attractive upside, but investors should also consider that Walgreen and CVS Caremark could benefit even more.

    Comment?

  18. Pharma Stocks Could Be in Deep Trouble in 2015. Here's Why.Read the original story w/Photo

    Dec 28, 2014 | The Motley Fool

    ... need to accept that this payer pushback against pricey new drugs is rapidly becoming an industrywide issue. CVS Caremark, ) excluded a whopping 95 brand-name drugs from its formulary for 2015, and said this list could grow to 200 in the final ...

    Comment?

  19. 2015: the year businesses recognize that climate change is realRead the original story

    Dec 26, 2014 | Canadian Content

    ... Unilever set ever more aggressive and inclusive goals and created marketing plans to persuade others to join. CVS Caremark disrupted its sector by announcing that it would stop selling tobacco and would rebrand itself as CVS Health to better align ...

    Comment?

  20. Walgreen Q1 Earnings Top On Strong Prescription SalesRead the original story w/Photo

    Dec 23, 2014 | Investor's Business Daily

    On Tuesday, the drugstore chain reported a 12.5% increase in earnings to 81 cents per share. Analysts polled by Thomson Reuters were expecting 75 cents.

    Comment?